Quest Diagnostics
DGX
$134.55
Share price
-0.83%
Change (1 day)
2.51%
Change (1 year)
Categories
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.
Quest Diagnostics (DGX) - P/B ratio
P/B ratio as of June 2023 : 2.45
According to Quest Diagnostics
's latest financial reports the company has a price-to-book ratio of 2.45.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Quest Diagnostics - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 2.97 | -8.3% |
| 2021-12-31 | 3.23 | 38.78% |
| 2020-12-31 | 2.33 | -5.43% |
| 2019-12-31 | 2.46 | 17.16% |
| 2018-12-31 | 2.10 | -21.1% |
| 2017-12-31 | 2.67 | -0.87% |
| 2016-12-31 | 2.69 | 26.46% |
| 2015-12-31 | 2.13 | -4.63% |
| 2014-12-31 | 2.23 | 14.93% |
| 2013-12-31 | 1.94 | -11.96% |
| 2012-12-31 | 2.20 | -10.6% |
| 2011-12-31 | 2.47 | 8.49% |
| 2010-12-31 | 2.27 | -17.62% |
| 2009-12-31 | 2.76 | -2.05% |
| 2008-12-31 | 2.82 | -8.83% |
| 2007-12-31 | 3.09 | -9.25% |
| 2006-12-31 | 3.40 | -7.92% |
| 2005-12-31 | 3.70 | -12.48% |
| 2004-12-31 | 4.23 | 34.6% |
| 2003-12-31 | 3.14 | -0.39% |
| 2002-12-31 | 3.15 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 LabCorp LH | 1.86 | -23.93% | 🇺🇸 USA |
 Psychemedics PMD | 2.54 | 3.71% | 🇺🇸 USA |
 NeoGenomics
NEO | 2.10 | -14.09% | 🇺🇸 USA |
 Qiagen QGEN | 2.98 | 21.95% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | 3.32 | 35.65% | 🇺🇸 USA |